Combination of Spartalizumab, mDCF and Radiotherapy in Patients With Metastatic Squamous Cell Anal Carcinoma
Clinical trial NCT04894370 · RECRUITING
Trial details
- NCT number
- NCT04894370
- Sponsor
- Centre Hospitalier Universitaire de Besancon
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-09
- Primary completion
- 2025-06-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.